Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...

The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

Read More: Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to know The growing demand for GLP-1 drugs, which mimic hormones that regulate ...

The long quest for powerful non-opioid drugs that treat pain without risk ... yoga, pool exercises, diet or even acupuncture, said Brett R. Stacey, a researcher and specialist at the Center ...

The prescription ... found that people's weight loss tends to halt at about 12 months. Outside clinical trials experts have suggested one reason why the blockbuster drug may not be performing ...